» Articles » PMID: 10625176

Agreement Between Self-assessment of Melanocytic Nevi by Patients and Dermatologic Examination

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 2000 Jan 7
PMID 10625176
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The number of melanocytic nevi is the strongest risk factor for cutaneous melanoma. As pigmented skin lesions are visible to everybody, the question has been raised about whether people can identify themselves as being at risk for melanoma through self-counting of moles. In 1991, a total of 513 central European melanoma patients and 498 controls were asked to count the total number of nevi and the number of atypical nevi on the whole body. Whole-body examination by dermatologists followed. Agreement was assessed on categorized nevus counts by means of ordinal kappa values and log-linear modeling. Study subjects significantly underestimated the total number of melanocytic nevi (p < 0.0001). Chance-corrected overall agreement was rather poor (kappa = 0.14), and the ability to detect many existing nevi was low. Agreement was higher for atypical melanocytic nevi counts (kappa = 0.37), and the sensitivity to detect more than one atypical nevus was 0.48. Self-assessment of the number of melanocytic nevi was difficult to perform accurately, and people severely underestimated the actual number. Despite these results, people should be encouraged to perform regular skin self-examination for early detection of melanoma.

Citing Articles

The Level of Agreement between Self-Assessments and Examiner Assessments of Melanocytic Nevus Counts: Findings from an Evaluation of 4548 Double Assessments.

Gefeller O, Kaiser I, Brockmann E, Uter W, Pfahlberg A Curr Oncol. 2024; 31(4):2221-2232.

PMID: 38668067 PMC: 11048774. DOI: 10.3390/curroncol31040164.


Suggested methodology for longitudinal evaluation of nevi based on clinical images.

Reiter O, Musthaq S, Kurtansky N, Barrios D, Halpern A, Marchetti M Skin Res Technol. 2021; 28(1):71-74.

PMID: 34455638 PMC: 9907704. DOI: 10.1111/srt.13092.


Height, nevus count, and risk of cutaneous malignant melanoma: Results from 2 large cohorts of US women.

Li X, Kraft P, De Vivo I, Giovannucci E, Liang L, Nan H J Am Acad Dermatol. 2020; 83(4):1049-1056.

PMID: 32376423 PMC: 9242091. DOI: 10.1016/j.jaad.2020.04.158.


Role of community pharmacists in skin cancer screening: A descriptive study of skin cancer risk factors prevalence and photoprotection habits in Barcelona, Catalonia, Spain.

Mir J, Estrada-Campmany M, Heredia A, Rodriguez-Caba C, Alcalde M, Espinosa N Pharm Pract (Granada). 2019; 17(3):1455.

PMID: 31592287 PMC: 6763307. DOI: 10.18549/PharmPract.2019.3.1455.


Cutaneous nevi and risk of melanoma death in women and men: A prospective study.

Li W, Cho E, Weinstock M, Li S, Stampfer M, Qureshi A J Am Acad Dermatol. 2019; 80(5):1284-1291.

PMID: 30639880 PMC: 6462416. DOI: 10.1016/j.jaad.2018.12.058.